Drug:
Reaction: INJECTION SITE ERYTHEMA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940078 |
US |
60 | 2 |
Fatigue, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site pain, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 2 | 26940223 |
US |
46 | 2 |
Injection site erythema, Injection site swelling, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 3 | 26940329 |
US |
72 | 1 |
Blood pressure fluctuation, Heart rate increased, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ERGOCALCIFEROL, MAGNESIUM, MAGNESIUM, TADALAFIL, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 4 | 26940483 |
US |
8 | 1 |
Injection site erythema, Injection site pain, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 5 | 26940560 |
US |
2 | |
Knee operation, Injection site haematoma, Constipation, Injection site bruising, Injection site erythema, Palpitations, Incorrect dose administered, Off label use, Product dose omission issue, Product administration interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CELECOXIB, CELECOXIB, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, |
||||
| 6 | 26940589 |
US |
20 | 2 |
Injection site pain, Injection site mass, Injection site pruritus, Injection site erythema, Injection site pain, Injection site haemorrhage, Injection site mass, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 7 | 26940600 |
US |
2 | |
Abdominal discomfort, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 8 | 26940616 |
US |
2 | |
Injection site pruritus, Injection site erythema, Drug ineffective, Injection site reaction, |
||||
EVOLOCUMAB, |
||||
| 9 | 26940617 |
US |
2 | |
Blood pressure decreased, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 10 | 26940633 |
US |
2 | |
Injection site warmth, Injection site erythema, |
||||
ABALOPARATIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, TICAGRELOR, CARVEDILOL, CLONAZEPAM, ENALAPRIL, TERIPARATIDE, |
||||
| 11 | 26941125 |
US |
35 | 1 |
Skin exfoliation, Injection site erythema, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 12 | 26941222 |
US |
85 | 2 |
Injection site bruising, Injection site erythema, Accidental exposure to product, Exposure via skin contact, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 13 | 26941226 |
US |
1 | |
Deep vein thrombosis, Pulmonary embolism, Injection site erythema, Injection site pruritus, |
||||
EVOLOCUMAB, |
||||
| 14 | 26941267 |
US |
2 | |
Injection site erythema, Injection site induration, |
||||
TIRZEPATIDE, |
||||
| 15 | 26941268 |
US |
50 | 2 |
Injection site erythema, Injection site inflammation, Injection site pruritus, Injection site mass, |
||||
TIRZEPATIDE, |
||||
| 16 | 26941691 |
US |
66 | 1 |
Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 17 | 26941752 |
US |
79 | 2 |
Chest pain, Injection site erythema, Heart rate increased, Palpitations, Headache, Fatigue, Product administered at inappropriate site, Off label use, Cardiac disorder, Cardiac flutter, Blood calcium increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMIODARONE HYDROCHLORIDE, RIVAROXABAN, |
||||
| 18 | 26941881 |
US |
2 | |
Injection related reaction, Burning sensation, Injection site irritation, Pain, Pruritus, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 19 | 26942085 |
US |
68 | 2 |
Injection site haemorrhage, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 20 | 26942420 |
US |
27 | 2 |
Injection site erythema, Injection site rash, |
||||
DUPILUMAB, DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS, MELATONIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 21 | 26942432 |
US |
1 | |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 22 | 26942572 |
US |
62 | 1 |
Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 23 | 26942830 |
US |
23 | 1 |
Injection site pruritus, Injection site irritation, Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 24 | 26942858 |
US |
50 | 2 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 25 | 26942864 |
US |
1 | |
Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, EPINEPHRINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 26 | 26943057 |
CA |
||
Drug ineffective, Pain in extremity, Wound, Injection site irritation, Injection site erythema, Urticaria, Blood immunoglobulin G increased, Injection site pruritus, Peripheral swelling, Gastrointestinal disorder, Impaired healing, Injection site pain, Blood immunoglobulin G decreased, Illness, Discomfort, Rash, Fear of injection, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, HUMAN IMMUNOGLOBULIN G, PRAZOSIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, PREGABALIN, DIMENHYDRINATE, SERTRALINE HYDROCHLORIDE, SUMATRIPTAN SUCCINATE, |
||||
| 27 | 26943265 |
US |
47 | 2 |
Injection site swelling, Injection site erythema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 28 | 26943601 |
US |
1 | |
Hypoacusis, Injection site erythema, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FUROSEMIDE, EMPAGLIFLOZIN, MELOXICAM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, MONTELUKAST, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PREDNISONE, SPIRONOLACTONE, ERGOCALCIFEROL, |
||||
| 29 | 26943765 |
US |
58 | 2 |
Osteopenia, Injection site erythema, Injection site discomfort, Intentional product misuse, |
||||
ANAKINRA, |
||||
| 30 | 26944040 |
US |
2 | |
Injection site erythema, Injection site induration, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 31 | 26944496 |
US |
59 | 1 |
Off label use, Injection site rash, Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, FINASTERIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ATORVASTATIN CALCIUM, OXYBUTYNIN, LORATADINE, LORATADINE TABLET, |
||||
| 32 | 26944824 |
US |
2 | |
Blood urine present, Gastrooesophageal reflux disease, Balance disorder, Polyuria, Musculoskeletal discomfort, Blood pressure increased, Injection site pain, Injection site erythema, Injection site swelling, Injection site reaction, Nausea, Fatigue, Vertigo, Asthenia, Renal disorder, Blood glucose increased, Product dose omission issue, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, HYOSCYAMINE SULFATE, MAGNESIUM, FLUTICASONE PROPIONATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TAMSULOSIN HYDROCHLORIDE, PEPPERMINT OIL, |
||||
| 33 | 26944904 |
US |
62 | 2 |
Hereditary angioedema, Unadjusted dose administered, Pain, Injection site erythema, Injection site scar, Therapeutic product effect delayed, |
||||
SEBETRALSTAT, |
||||
| 34 | 26945026 |
US |
2 | |
Somnolence, Illness, Blood pressure decreased, Decreased appetite, Injection site pain, Injection site erythema, Injection site swelling, Back pain, Nausea, Dizziness, Fatigue, |
||||
ABALOPARATIDE, FEXOFENADINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BIOTIN, DIPHENHYDRAMINE HYDROCHLORIDE, CALCIUM, FISH OIL, FLUTICASONE PROPIONATE, LORAZEPAM, POLYETHYLENE GLYCOL 3350, MONTELUKAST, RIMEGEPANT SULFATE, MAGNESIUM, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM AND SENNOSIDES, SENNOSIDES AND DOCUSATE SODIUM, DOCUSATE SODIUM SENNOSIDES, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 35 | 26945115 |
US |
2 | |
Pain in jaw, Blood pressure decreased, Tinnitus, Blood pressure increased, Dizziness, Injection site erythema, Injection site pruritus, Injection site rash, Headache, Insomnia, Therapeutic response unexpected, Off label use, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 36 | 26945151 |
US |
64 | 2 |
Injection site reaction, Injection site pruritus, Injection site rash, Injection site urticaria, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 37 | 26945290 |
US |
2 | |
Injection site discolouration, Injection site nodule, Injection site erythema, Injection site pain, Liquid product physical issue, |
||||
ABALOPARATIDE, |
||||
| 38 | 26945394 |
US |
2 | |
Injection site mass, Hyperaesthesia teeth, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 39 | 26945548 |
US |
2 | |
Nausea, Bone pain, Injection site erythema, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ESOMEPRAZOLE MAGNESIUM, PROPRANOLOL HYDROCHLORIDE, SIMVASTATIN, |
||||
| 40 | 26945621 |
US |
1 | |
Injection site irritation, Injection site pain, Injection site bruising, Injection site swelling, Injection site erythema, Injection site reaction, |
||||
ABALOPARATIDE, |
||||
| 41 | 26945843 |
US |
67 | 2 |
Flushing, Mouth swelling, Local reaction, Erythema, Papule, Injection site pain, Injection site erythema, Pruritus, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 42 | 26945884 |
US |
63 | 2 |
Injection site irritation, Bone disorder, Muscle discomfort, Nasopharyngitis, Feeling abnormal, Injection site erythema, Injection site bruising, Back pain, Dyspnoea, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 43 | 26945896 |
US |
73 | 2 |
Injection site haemorrhage, Injection site erythema, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 44 | 26945959 |
US |
2 | |
Feeling jittery, Injection site pruritus, Injection site erythema, Injection site swelling, Headache, Heart rate increased, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 45 | 26945962 |
US |
2 | |
Viral infection, Injection site induration, Malaise, Muscle spasms, Injection site bruising, Injection site erythema, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 46 | 26946159 |
US |
2 | |
Chest discomfort, Dyspepsia, Dyspnoea, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 47 | 26946200 |
US |
62 | 2 |
Rash papular, Injection site erythema, Pruritus, Headache, Injection site pain, Needle issue, |
||||
ABALOPARATIDE, PREDNISONE, |
||||
| 48 | 26946208 |
US |
2 | |
Injection site urticaria, Fatigue, Headache, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 49 | 26946242 |
US |
2 | |
Gastrointestinal disorder, Myalgia, Palpitations, Dizziness, Nausea, Injection site erythema, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 50 | 26946280 |
US |
2 | |
Injection site pain, Injection site erythema, Injection site bruising, Injection site haematoma, Adverse drug reaction, Fear of injection, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 51 | 26946356 |
US |
33 | 2 |
Injection site irritation, Injection site erythema, Off label use, |
||||
ABALOPARATIDE, |
||||
| 52 | 26946541 |
US |
2 | |
Injection site irritation, Nausea, Palpitations, Injection site bruising, Injection site erythema, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, CALCIUM, CYANOCOBALAMIN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 53 | 26946713 |
US |
2 | |
Injection site irritation, Central obesity, Injection site erythema, Injection site rash, Injection site pruritus, |
||||
ABALOPARATIDE, |
||||
| 54 | 26946766 |
US |
2 | |
Feeding disorder, Illness, Injection site discharge, Abdominal discomfort, Headache, Nausea, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 55 | 26946772 |
US |
2 | |
Allergy to vaccine, Heart rate increased, Headache, Weight increased, Injection site erythema, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 56 | 26946784 |
US |
2 | |
Mood altered, Depressed mood, Head discomfort, Euphoric mood, Brain fog, Injection site erythema, Headache, Bone pain, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 57 | 26946794 |
US |
67 | 2 |
Injection site urticaria, Weight decreased, Decreased appetite, Injection site erythema, Injection site pruritus, Fatigue, Bone pain, Headache, Pain in extremity, Diarrhoea, Dizziness, Blood calcium increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 58 | 26946857 |
US |
2 | |
Emergency care, Sensory disturbance, Swollen tongue, Injection site erythema, Headache, Rash, Hypersensitivity, |
||||
ABALOPARATIDE, |
||||
| 59 | 26946995 |
US |
2 | |
Injection site mass, Injection site erythema, Injection site pruritus, Product dose omission in error, Product administered at inappropriate site, |
||||
ABALOPARATIDE, |
||||
| 60 | 26947057 |
US |
2 | |
Injection site mass, Pruritus, Injection site erythema, |
||||
ABALOPARATIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, FISH OIL, |
||||
| 61 | 26947064 |
US |
67 | 2 |
Injection site erythema, Injection site pruritus, Drug effect less than expected, |
||||
ABALOPARATIDE, |
||||
| 62 | 26947131 |
US |
2 | |
Asthenia, Diarrhoea, Injection site erythema, Injection site swelling, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 63 | 26947183 |
US |
2 | |
Injection site irritation, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 64 | 26947192 |
US |
2 | |
Urticaria, Injection site erythema, Injection site pruritus, Rash, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 65 | 26947251 |
US |
2 | |
Injection site urticaria, Eye pruritus, Hypersensitivity, Injection site pruritus, Injection site erythema, Pain, Injection site pain, Injection site rash, |
||||
ABALOPARATIDE, ABALOPARATIDE, ERGOCALCIFEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 66 | 26947389 |
US |
2 | |
Injection site erythema, Urticaria, |
||||
ABALOPARATIDE, |
||||
| 67 | 26947390 |
US |
1 | |
Asthenia, Abdominal pain, Injection site erythema, Skin discolouration, Amnesia, Blood calcium abnormal, |
||||
ABALOPARATIDE, ERGOCALCIFEROL, ALLOPURINOL, ACYCLOVIR, LOSARTAN POTASSIUM, LOSARTAN, RIVAROXABAN, TORSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LEVOTHYROXINE SODIUM, |
||||
| 68 | 26947546 |
US |
2 | |
Injection site swelling, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 69 | 26947707 |
US |
2 | |
Abdominal rigidity, Gastrointestinal disorder, Abdominal distension, Injection site pain, Injection site bruising, Injection site swelling, Injection site erythema, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 70 | 26947718 |
US |
2 | |
Influenza, Anaemia, Vitamin D increased, Injection site erythema, Injection site bruising, Injection site pain, Blood calcium increased, |
||||
ABALOPARATIDE, OLOPATADINE HYDROCHLORIDE, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, BUDESONIDE, CALCIUM, BIOTIN, MAGNESIUM, CETIRIZINE HCL, CETIRIZINE, ERGOCALCIFEROL, |
||||
| 71 | 26947751 |
US |
61 | 2 |
Adverse drug reaction, Injection site erythema, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 72 | 26947771 |
US |
2 | |
Injection site irritation, Injection site urticaria, Injection site erythema, Arthralgia, Injection site bruising, Injection site pruritus, Heart rate increased, |
||||
ABALOPARATIDE, |
||||
| 73 | 26947838 |
US |
2 | |
Erythema, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 74 | 26947865 |
US |
2 | |
Hypotension, Nausea, Fatigue, Pain, Dizziness, Heart rate increased, Injection site erythema, Palpitations, Injection site reaction, |
||||
ABALOPARATIDE, |
||||
| 75 | 26948032 |
US |
75 | 1 |
Spinal operation, Hypoaesthesia, Injection site discomfort, Injection site induration, Myalgia, Arthralgia, Pain in extremity, Dizziness, Vertigo, Heart rate increased, Injection site erythema, Injection site haemorrhage, Injection site bruising, |
||||
ABALOPARATIDE, |
||||
| 76 | 26948072 |
AU |
65 | 1 |
Suicidal ideation, Injection site erythema, Inappropriate schedule of product administration, Depression, Presyncope, Blood pressure systolic decreased, |
||||
ROZANOLIXIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 77 | 26948150 |
US |
71 | 2 |
Rosacea, Dry mouth, Dysgeusia, Taste disorder, Heart rate increased, Dizziness, Palpitations, Diarrhoea, Fatigue, Injection site erythema, Injection site pruritus, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, MAGNESIUM, CYANOCOBALAMIN, ERGOCALCIFEROL, VITAMIN C, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 78 | 26948164 |
US |
2 | |
Retching, Gait disturbance, Palpitations, Nausea, Dizziness, Injection site pain, Injection site erythema, Injection site swelling, Headache, Heart rate increased, Fatigue, Abdominal pain upper, Vertigo, Off label use, Device use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 79 | 26948279 |
US |
56 | 2 |
Visual impairment, Hypersomnia, Food craving, Feeding disorder, Visual impairment, Photopsia, Myalgia, Bedridden, Unevaluable event, Joint swelling, Injection site erythema, Injection site pain, Abdominal pain upper, Headache, Injection site bruising, Illness, Fatigue, Nausea, Vomiting, Dizziness, Arthralgia, Lethargy, Asthenia, Abdominal pain, Product storage issue, Product storage issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, BUPROPION, GLYCERIN, METHOCARBAMOL, METHOCARBAMOL TABLETS, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, PEPPERMINT OIL, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 80 | 26934087 |
US |
55 | 2 |
Injection site erythema, Injection site pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, VITAMIN C, |
||||
| 81 | 26934250 |
US |
70 | 2 |
Injection site erythema, |
||||
IXEKIZUMAB, |
||||
| 82 | 26934594 |
US |
39 | 2 |
Injection site papule, Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 83 | 26934671 |
US |
76 | 2 |
Injection site erythema, Injection site inflammation, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 84 | 26934765 |
JP |
38 | 2 |
Injection site erythema, Injection site induration, Pruritus, Erythema, |
||||
GARADACIMAB, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, ZOLPIDEM TARTRATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, PREGABALIN, SENNOSIDES, FAMOTIDINE, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, OMALIZUMAB, |
||||
| 85 | 26934827 |
US |
67 | 2 |
Insomnia, Injection site erythema, Injection site rash, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 86 | 26934859 |
US |
24 | 1 |
Injection site erythema, Injection site warmth, |
||||
DUPILUMAB, |
||||
| 87 | 26935115 |
US |
30 | 2 |
Injection site mass, Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 88 | 26935303 |
US |
80 | 2 |
Injection site pain, Injection site erythema, Incorrect route of product administration, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 89 | 26935320 |
US |
62 | |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 90 | 26935333 |
US |
73 | 1 |
Injection site pain, Injection site erythema, Dry eye, |
||||
DUPILUMAB, |
||||
| 91 | 26935484 |
US |
38 | 2 |
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 92 | 26935738 |
US |
65 | |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 93 | 26935972 |
US |
2 | |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 94 | 26936094 |
US |
59 | 2 |
Incorrect dose administered, Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 95 | 26936200 |
US |
68 | |
Pneumonia bacterial, Ear infection bacterial, Sinusitis bacterial, Viral infection, Injection site urticaria, Injection site pruritus, Injection site erythema, |
||||
ALIROCUMAB, |
||||
| 96 | 26936425 |
US |
||
Injection site erythema, Injection site swelling, Injection site pruritus, Injection site warmth, |
||||
FREMANEZUMAB-VFRM, FREMANEZUMAB-VFRM, |
||||
| 97 | 26936674 |
US |
79 | 2 |
Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 98 | 26937307 |
CA |
42 | |
Haematochezia, Feeling of body temperature change, Erythema, Injection site erythema, Hot flush, Fatigue, Hyperhidrosis, Diarrhoea, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, |
||||
| 99 | 26937564 |
US |
2 | |
Ehlers-Danlos syndrome, Sensitive skin, Injection site reaction, Contusion, Injection site erythema, |
||||
ASFOTASE ALFA, |
||||
| 100 | 26937583 |
US |
13 | 1 |
Extravasation, Injection site erythema, Injection site swelling, Device issue, Product dispensing issue, Device occlusion, |
||||
ETEPLIRSEN, ETEPLIRSEN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30